Skip to content

Clinical trials

Leukemia, Lymphocytic, Chronic, B-Cell trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Country / region: Israel Clear all

70 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20061
20081
20093
20103
20112
20123
20136
20141
20159
20164
20172
20181
20194
20204
20215
20225
20236
20241
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Active, not recruiting19
Terminated12
Recruiting6
Unknown status3
Not yet recruiting1
Suspended1
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC9
AbbVie8
Acerta Pharma BV5
Hoffmann-La Roche4
Merck Sharp & Dohme LLC4
European Organisation for Research and Treatment of Cancer - EORTC3
Loxo Oncology, Inc.3
Pharmacyclics LLC.3
TG Therapeutics, Inc.3
BeOne Medicines2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell70
Lymphoma, Non-Hodgkin21
Lymphoma, Follicular14
Lymphoma, Large B-Cell, Diffuse13
Lymphoma, Mantle-Cell11
Neoplasms11
Lymphoma, B-Cell, Marginal Zone10
Waldenstrom Macroglobulinemia10
Leukemia8
Recurrence8

Trials

Showing 76 to 70 of 70. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.